NOTIFICATION: The Technology Channels will soon be discontinued.
Click here to download complimentary copies of Fastmarkets RISI’s pulp and paper newsletters.

 

Circa Group appoints Sarah Hickingbottom as new GM for product development and stakeholder relations

Read so far

Circa Group appoints Sarah Hickingbottom as new GM for product development and stakeholder relations

March 31, 2021 - 04:18
Posted in:

OSLO, Norway, March 31, 2021 (Press Release) -Sustainable biochemicals company Circa Group AS has announced that Dr Sarah Hickingbottom has joined the company as General Manager for New Product Development and Stakeholder Relations on 29 March 2021.

Dr Hickingbottom was previously CEO of BioVale, a bioeconomy innovation cluster based in Yorkshire, UK. She has extensive global consultancy experience from LMC International and Frost & Sullivan advising brand owners, chemical manufacturers and agricultural producers on oleochemicals, bio-based chemicals and fuels, including markets, feedstocks, economics, policy, innovation and scale-up. Her Organic Chemistry PhD is from University of California, Los Angeles (UCLA).

Following Circa’s successful IPO in March 2021, this new role adds capabilities to deliver on Circa’s strategy to develop and commercialise derivatives of Levoglucosenone (LGO). Dr Sarah Hickingbottom will work closely with customers across Circa’s networks, including with the BBI JU and Consortium members involved in the H2020 Flagship project ReSolute plant in Eastern France.

Tony Duncan, CEO and co-founder of Circa Group, said, “We are delighted that Sarah is joining us – her considerable skills and experience in a wide range of sustainable chemistry markets considerably strengthen Circa’s commercialisation objectives. Our sustainable Levoglucosenone platform offers considerable opportunity for industry to both replace current difficult petro-based molecules as well as consider molecules that until now have been prohibitively expensive to utilise in commercial applications.”

About Circa

Established in 2006, Circa Group converts waste, non-food biomass into advanced bio-based chemicals with its proprietary Furacell process. Its developing product portfolio includes flavours, biopolymers, and bio-solvents including Cyrene, an alternative to traditional polar aprotic solvents, which is produced in one step from platform biomolecule Levoglucosenone. By creating renewable chemicals from cellulose, Circa is extracting value from non-food, waste biomass and addressing a gap in the market by providing bio-based alternatives contributing to a more circular economy. In March 2021, Circa Group successfully listed on the Euronext Growth Market in Oslo, stock symbol CIRCA.